09:50 AM EST - Telesta Therapeutics Inc. : Announced receipt of a notice from the U.S. Food and Drug Administration confirming that it has organized an advisory committee to review Telesta's Biologics License Application for MCNA. This advisory committee will be held on Wednesday, November 18. Telesta Therapeutics Inc.
shares T.TST are trading up $0.015 at $0.43.
